On March 19, the innovative drug sector in the A-share market faced volatility and a downward trend. Kexing Biopharm Co.,Ltd. saw a decline of over 10%, leading the losses. Other notable decliners included Yinuosi, Haite Biology, Aidi Pharmaceutical, Haoyuan Pharmaceutical, and Beilu Pharmaceutical.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.